[Pneumocystis pneumonia in patients with immunosuppression other than HIV infection]

Rev Med Suisse. 2008 Nov 19;4(180):2525-6, 2528-30.
[Article in French]

Abstract

Pneumocystis jirovecii is an opportunistic pathogen causing life-threatening pneumonia in immunosuppressed patients. The number of non-HIV immunosuppressed patients at risk for Pneumocystis pneumonia is rapidly growing. In contrast to HIV patients, there are no guidelines for Pneumocystis prophylaxis in other immunocompromised hosts. A detailed analysis of current literature data allowed us hereby to define the type of immunocompromised patients for whom evidence suggests a benefit for PCP prophylaxis.

Publication types

  • Review

MeSH terms

  • Anti-Infective Agents / administration & dosage*
  • Connective Tissue Diseases / complications
  • Drug-Related Side Effects and Adverse Reactions
  • Evidence-Based Medicine
  • HIV Infections*
  • Humans
  • Immunocompromised Host*
  • Neoplasms / complications
  • Pneumocystis carinii*
  • Pneumonia, Pneumocystis / prevention & control*
  • Practice Guidelines as Topic
  • Protein-Energy Malnutrition / complications
  • Randomized Controlled Trials as Topic
  • Risk Factors
  • Transplantation / adverse effects
  • Treatment Outcome
  • Trimethoprim, Sulfamethoxazole Drug Combination / administration & dosage*
  • Vasculitis / complications

Substances

  • Anti-Infective Agents
  • Trimethoprim, Sulfamethoxazole Drug Combination